Phase II trial of taxol in patients with metastatic renal cell carcinoma

Avi I. Einzig, Elizabeth Gorowski, Jill Sasloff, Peter H. Wiernik

Research output: Contribution to journalArticle

37 Scopus citations


Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

Original languageEnglish (US)
Pages (from-to)133-136
Number of pages4
JournalCancer Investigation
Issue number2
Publication statusPublished - Jan 1 1991


ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this